Microbial Determinants of Immune Activation and Clinical Outcome in Lung Tumor Subtypes

Valdés Ivania; Alberto Mantovani; Eduardo Ribes Martínez; Pérez Besollo Francisco; Troncoso Paulina; Carrie R. Daniel; Barbara Miziak; Prado Carolina; Nova-Lamperti Estefanía; Galindo Hector; C. Ignacio; Pérez-Jeldres Tamara; Ondřej Fabián; Zoroquiain Pablo; McAllister Florencia; Riquelme Erick

doi:10.21203/rs.3.rs-6979772/v1

Related publications

Article1990

Muscarinic Receptor Subtypes in Lung: Clinical Implications

Philippe Minette, Peter J Barnes

Article2018

Criticality in tumor evolution and clinical outcome

Erez Persi, Yuri I. Wolf, Mark D.M. Leiserson, Eugene V Koonin, Eytan Ruppin

Preprint2018

Criticality in Tumor Evolution and Clinical Outcome

Erez Persi, Yuri I. Wolf, Mark D.M. Leiserson, Eugene V Koonin, Eytan Ruppin

Article2015

Effect of mutant TP53 genotypes on the outcome of breast cancer (BC) patients in different clinical tumor subtypes.

George Fountzilas, Meletios A Dimopoulos, George Kouvatseas, Eleni Timotheadou, George Pentheroudakis, Helen Gogas, Dimitrios Pectasides, Christos Christodoulou, Elpida Charalambous, Aggeliki Lyberopoulou, Helena Linardou, Christos N. Papandreou, Amanda Psyrri, Gerasimos Aravantinos, Christos Markopoulos, Vasileios Venizelos, Ioannis Efstratiou, Konstantine T. Kalogeras, Sotiris Lakis, Vassiliki Kotoula

Article2003

Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer.

Rosa Ana Risques, Vı́ctor Moreno, Maria Ribas, Eugenio Marcuello, Gabriel Capellà, Aaa Bbb